Disease Presentation and Progression of COVID Patients with Modified Tinea

Background: Dermatophytes causes superficial skin hair and nail infections, which is becoming epidemic in India even during the COVID19 pandemic period. Superficial dermatophytosis has evolved as a difficult to treat, chronic (greater than1year) extensive, recurrent, persistent, widespread recalcitrant infection and has emerged as a major public health problem in our country. Potent steroid molecules in the combination/OTC creams cause local immuno-suppression, barrier dysfunction and increase multiplication of the dermatophytes resulting in persistent infection. The term ?Steroid modified dermatophytosis? is used when the clinical morphology of dermatophytosis can be recognised in spite of application of topical corticosteroids. The term ?Tinea incognito? refers to the situation in which the clinical morphology is so altered that dermatophytosis is unrecognizable, due to the application of topical corticosteroid creams or use of OTC creams. Aim: disease presentation and progression of COVID patients with modified Tinea. Materials & Method: This is a clinico-epidemiology study of modified Tinea infections patients with received at the Dermatology OPD of Shadan Institute of Medical Sciences, Research Center & Teaching Hospital in the COVID 19 phase January 15th 2021-August 31st 2021 which were prevalent in the surrounding geographical district of Peeramcheru, Hyderabad, Telangana. Results: modified Tinea is more common in males with age group of 35-40 yrs, low socioeconomic status, Pseudoimbricata as common presentation, Tinea Cruris & Corporis most common type and OTC as most common aggrevator. Conclusion: In a time when India was fighting Mucormycoiss/Aspergilosis /Candidiasis it was due to given circumstances it became even harder to treat dermatophytosis, which is still an ongoing predicament.